precision medicine companies

Companies whose enriched business profile is tagged “precision medicine”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + market data, shown with its as-of date.

• Agilent Technologies (A) Health Care — A diversified healthcare and life sciences company providing analytical instruments, software, and services for pharmaceutical, chemical, and clinical diagnostics laboratories worldwide. ask →
• GE HealthCare (GEHC) Health Care — GE HealthCare is a leading global medical technology provider delivering advanced diagnostic imaging, clinical systems, and intelligent digital solutions to healthcare providers worldwide. ask →
• Illumina, Inc. (ILMN) Health Care — Illumina provides the essential genetic sequencing and array platforms that power modern genomic research and clinical diagnostics. ask →
• Alnylam Pharmaceuticals (ALNY) Health Care — Alnylam is a pioneer in RNA interference (RNAi) therapeutics, using gene-silencing technology to treat rare genetic diseases and cardiovascular conditions. ask →
• Labcorp (LH) Health Care — Labcorp is a leading global life sciences company providing essential clinical diagnostic testing and drug development services to the healthcare industry. ask →
• Quest Diagnostics (DGX) Health Care — A leading national provider of diagnostic testing and medical insights, delivering clinical laboratory services through an extensive network of patient centers and hospitals. ask →
• BridgeBio Pharma, Inc. (BBIO) Health Care — BridgeBio is a portfolio-based biotech firm focused on translating genetic science into precision therapies for patients with severe genetic disorders. ask →
• ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Health Care — Arrowhead Pharmaceuticals is a clinical-stage biotechnology company leveraging its proprietary RNA interference (RNAi) platform to develop potent medicines that silence disease-causing genes. ask →
• PRAXIS PRECISION MEDICINES INC (PRAX) Health Care — Praxis Precision Medicines is a clinical-stage biopharmaceutical company developing precision therapies for central nervous system disorders driven by neuronal imbalance. ask →
• Tempus AI (TEM) Health Care — Tempus AI leverages a massive library of multimodal clinical and molecular data to power AI-driven precision medicine for patients and researchers. ask →
• CRINETICS PHARMACEUTICALS INC (CRNX) Health Care — Crinetics Pharmaceuticals is a clinical-stage biotechnology company developing small molecule precision medicines for rare endocrine diseases and related tumors. ask →
• Qiagen (QGEN) Health Care — QIAGEN provides essential sample-to-insight technologies that empower researchers and clinicians to unlock molecular and genetic information from biological samples. ask →
• TWIST BIOSCIENCE CORP (TWST) Health Care — Twist Bioscience leverages a proprietary silicon-based platform to mass-produce high-quality synthetic DNA for applications in therapeutics, diagnostics, and research. ask →
• RHYTHM PHARMACEUTICALS INC (RYTM) Health Care — Rhythm Pharmaceuticals is a biopharmaceutical company specializing in precision therapies for rare genetic and neuroendocrine disorders characterized by severe obesity and hyperphagia. ask →
• 10X GENOMICS INC CLASS A (TXG) Health Care — 10x Genomics provides advanced single-cell and spatial biology platforms that empower researchers to decode complex biological systems at high resolution. ask →
• Caris Life Sciences (CAI) Health Care — Caris Life Sciences delivers comprehensive molecular profiling and precision medicine insights to optimize oncology treatment and drug development. ask →
• COGENT BIOSCIENCES INC (COGT) Health Care — A clinical-stage biotechnology company developing precision protein kinase inhibitors for oncology and genetically defined diseases. ask →
• ERASCA INC (ERAS) Health Care — Erasca is a precision oncology company dedicated to shutting down the RAS/MAPK pathway to effectively treat patients with cancer. ask →
• EDGEWISE THERAPEUTICS INC (EWTX) Health Care — A clinical-stage biopharmaceutical company developing oral, precision small molecule medicines for the treatment of serious cardiovascular diseases. ask →
• ENLIVEN THERAPEUTICS INC (ELVN) Health Care — Enliven Therapeutics is a precision oncology company developing next-generation small molecule inhibitors, led by its clinical-stage BCR-ABL program for chronic myeloid leukemia. ask →
• RELAY THERAPEUTICS INC (RLAY) Health Care — Relay Therapeutics is a precision medicine company leveraging a protein-motion discovery platform to develop targeted therapies for oncology and genetic diseases. ask →
• IDEAYA BIOSCIENCES INC (IDYA) Health Care — IDEAYA Biosciences is a clinical-stage precision medicine company focused on discovering and developing targeted synthetic lethality therapies for oncology. ask →
• VERACYTE INC (VCYT) Health Care — Veracyte is a genomic diagnostics company transforming cancer care with advanced, high-value testing platforms across the patient journey from diagnosis to monitoring. ask →
• BEAM THERAPEUTICS INC (BEAM) Health Care — Beam Therapeutics is a biotechnology firm pioneering base editing technology to create next-generation precision genetic medicines. ask →
• NURIX THERAPEUTICS INC (NRIX) Health Care — Clinical-stage biotech pioneering AI-powered targeted protein degradation medicines for cancer and autoimmune diseases, with Phase 2 lead candidate bexobrutideg in CLL and partnerships spanning Roche, Gilead, and Sanofi. ask →
• GENEDX HOLDINGS CORP CLASS A (WGS) Health Care — GeneDx uses AI-powered genomics to provide precise, actionable clinical genetic testing for rare and complex diseases. ask →
• PRECIGEN INC (PGEN) Health Care — A commercial-stage precision medicine company leveraging proprietary adenoviral and CAR-T platforms to address intractable diseases, notably including the FDA-approved RRP therapy Papzimeos. ask →
• CAREDX INC (CDNA) Health Care — CareDx is a precision medicine leader providing diagnostic testing, digital health tools, and patient support services to improve outcomes for transplant and oncology patients. ask →
• KODIAK SCIENCES INC (KOD) Health Care — Kodiak Sciences is a clinical-stage biotech company developing next-generation, high-durability retinal medicines using its proprietary Antibody Biopolymer Conjugate (ABC) platform. ask →
• RAPPORT THERAPEUTICS INC (RAPP) Health Care — Rapport Therapeutics is a clinical-stage biotechnology company developing precision medicines for neurological disorders using its proprietary RAP platform to target specific neural circuits. ask →
• ALAMAR BIOSCIENCES INC (ALMR) Health Care — Alamar Biosciences is a proteomics company providing a high-sensitivity platform for precise protein biomarker detection and analysis to drive medical research and future diagnostics. ask →
• ORIC PHARMACEUTICALS INC (ORIC) Health Care — ORIC Pharmaceuticals is a clinical-stage oncology company developing targeted therapies for hard-to-treat cancers through precision medicine approaches. ask →
• MONTE ROSA THERAPEUTICS INC (GLUE) Health Care — Monte Rosa Therapeutics develops molecular glue degraders—a novel class of protein degradation drugs targeting historically undruggable proteins through its proprietary QuEEN discovery platform. ask →
• KURA ONCOLOGY INC (KURA) Health Care — Clinical-stage oncology company commercializing KOMZIFTI for cancer and advancing a pipeline of targeted therapeutics through strategic partnerships. ask →
• CASTLE BIOSCIENCES INC (CSTL) Health Care — Castle Biosciences is a molecular diagnostics company offering gene expression profile tests to improve management of dermatologic and gastrointestinal cancers. ask →
• CYTOMX THERAPEUTICS INC (CTMX) Health Care — CytomX is developing conditionally activated cancer therapies using its PROBODY platform to enable selective tumor targeting with reduced systemic toxicity, starting with varsetatug masetecan for colorectal cancer. ask →
• FULGENT GENETICS INC (FLGT) Health Care — Fulgent Genetics is a diagnostic laboratory that leverages proprietary technology to provide accessible, affordable, and actionable genetic testing for rare diseases, cancer, and reproductive health. ask →
• PRELUDE THERAPEUTICS INC (PRLD) Health Care — An early-stage biopharma company developing novel small-molecule drug candidates targeting protein-driven disease mechanisms. ask →
• FOGHORN THERAPEUTICS INC (FHTX) Health Care — Precision biotechnology company developing chromatin-targeting small molecule therapeutics to treat cancer and other serious diseases by correcting abnormal gene expression. ask →
• PERSPECTIVE THERAPEUTICS INC (CATX) Health Care — Perspective Therapeutics is a clinical-stage oncology company pioneering targeted alpha therapy (TAT) to treat cancer through a proprietary radiopharmaceutical platform. ask →
• NEUMORA THERAPEUTICS INC (NMRA) Health Care — Neumora Therapeutics is a clinical-stage biotechnology company developing precision medicine therapies for psychiatric and neurodegenerative brain disorders. ask →
• MYRIAD GENETICS INC (MYGN) Health Care — Myriad Genetics is a genetic testing company focused on providing actionable insights for cancer risk, reproductive health, and mental health clinical decisions. ask →
• ANAVEX LIFE SCIENCES CORP (AVXL) Health Care — A clinical-stage biopharma company developing precision medicine treatments for Alzheimer's, Parkinson's, and rare CNS diseases by targeting the sigma-1 receptor. ask →
• BIODESIX INC (BDSX) Health Care — Biodesix develops precision diagnostic tests powered by molecular and AI analysis to guide oncology treatment decisions for clinicians, payers, and biopharmaceutical companies. ask →
• ATRIUM THERAPEUTICS INC (RNA) Health Care — Atrium is an early-stage biotech pioneering antibody-conjugated RNA therapeutics to treat rare genetic cardiomyopathies by silencing disease-driving genes in the heart. ask →

Not quite it? Describe exactly what you want →

Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Figures shown with their as-of date.

Last updated 2026-08-25.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.